Treatment and prophylaxis of anthrax by new neurosecretory cytokines

Neurochemical Research

Volumn 31, Issue 6, 2006, Pages 795-803

  Galoyan, A A ^a   Grigoryan, S L ^b   Badalyan, K V ^a  

^a H Buniatian Institute of Biochemistry National Academy of Sciences of Armenia   (Armenia)

^b ARMENIAN NATIONAL AGRARIAN UNIVERSITY   (Armenia)

Author keywords

Anthrax; Antibiotic; Cytokines; Gx NH2; PRP 1; Vaccines

Indexed keywords

AMIDE; AMINO ACID; ANTHRAX VACCINE; ANTIINFECTIVE AGENT; CYTOKINE; IMMUNOMODULATING AGENT; POLYPEPTIDE; PROLINE; PROLINE DERIVATIVE; PROLINE RICH POLYPEPTIDE 1; UNCLASSIFIED DRUG;

AMIDATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTHRAX; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS ANTHRACIS; CONTROLLED STUDY; DRUG ACTIVITY; GUINEA PIG; HYPOTHALAMUS; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; LETHAL DOSE; MOUSE; NEUROSECRETION; NEUROSECRETORY CELL; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTHRAX; ANTI-BACTERIAL AGENTS; CULTURE MEDIA; CYTOKINES; GUINEA PIGS; HYPOTHALAMUS; MOLECULAR SEQUENCE DATA; SPORES, BACTERIAL;

ANIMALIA; BACILLUS ANTHRACIS; CAVIA;

EID: 33746374318     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-006-9082-2     Document Type: Article

References (30)

1. Brossier F, Weber-Levy M, Mock M, Sirard JC (2000) Role of toxin functional domains in anthrax pathogenesis. Infect Immun 68:1781-1786
2. Mourez M, Lacy DB, Conningham K et al. (2002) A year of major advances in anthrax toxin research. Trends Microbiol 10:287-293
3. Bradley KA, Young JAT (2003) Anthrax toxin receptor proteins. Biochem Pharmacol 65:309-314
4. Leppla SH (1982) Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentration in eukaryotic cells. PNAS USA 79:3162-3166
5. O'Brien J, Friedlander AM, Dreier T, Ezzell J, Leppla S (1985) Effects of anthrax toxin components on human neutrophils. Infect Immun 47:306-410
6. Ross JM (1957) The pathogenesis of anthrax following the administration of spores by the respiratory route. J Pathol Bacteriol 73:485-494
7. Hanna P (1998) Anthrax pathogenesis and host response. Curr Top Microbiol Immunol 225:13-35
8. Lalitha MK, Thomas MK (1997) Penicillin resistance in Bacillus anthracis. Lancet 349:1522
9. Chen Y, Succi J, Tenovez FC, Kochler TM (2003) Beta-Lactamase Genes of the Penicillin-Cusceptible Bacillus anthracis Sterne Strain. J Bacteriol 185:823-830
10. Swartz MN (2001) Recognition and management of anthrax - an update. N Engl J Med 345:1621-1626
11. Ressel G (2001) CDC updates interim gyidelines for anthrax exposure management and antimicrobal therapy. Am Fam Physicion 64:1901-1902
12. Borg MA, Tieck WC (2001) Responding to anthrax. J Dent Technol 18:12-14, 28
13. Brook J (2002) The prophylaxis and treatment of anthrax. Inf J Antimicrob Agents 20(5):320-325
14. Bryskier A (2002) Bacillus anthracis and antibacterial agents. Clin Microbiol Infect 8:467-478
15. Odendaal MW, Peterson PM, de Voc V, Botha AD (1991) The antibiotic sensitivity patterns of Bacillus anthracis isolated from the Kruger National park. Onderstepoort J Vct Res 58:17-19
16. Doganaya M, Aydin N 1991 Antimicrobial susceptibility of Bacillus anthracis. Scand J Infect Dis 23:333-335
17. Ingles TV, Handerson DA, Bartlett JG, et al. (1999) Anthrax as a biological weapon. JAMA 128(18):1735-1745
18. Aprikyan VS, Galoyan AA (1999) Immunecorrecting properties of a new hypothalamic polypeptide upon macrophage-associated bacterial dysfunction. Med Sci Armenia 31(4):29-36
19. Davtyan TK, Manukyan NA, Mkrtchyan R, Galoyan AA (2005) Hypothalamic Proline-Rich Polypeptide (PRP) is a regulator of human Neutrophils and Monocytes oxidative burst. Neurochem Res 3:297-309
20. Galoyan AA, Aprikyan VS (2002) A new hypothalamic peptide is a regulator of myelopoiesis. Neurochem Res 27:305-312
21. Aprikyan VS, Galoyan AA (2001) New hypothalamic peptides in regulation of thymocytes differentiation. Proceeding of the International conference "Biochemical and Molecular-Biological aspects of Brain Immune System. Encyclopedia Armenica publishing House, Yerevan, pp 183-189
22. Aprikyan VS, Galoyan AA (2000) Hypothalamic polypeptide protects mice from lethal challenge with gram-negative bacteria. Neurokhimya RAS NAS RA 17:60-63
23. Galoyan AA (2004) Brain neurosecretory cytokines; immune response and neuronal survival. Kluwer Academic/Plenum Publishers, New York, p 188
24. Galoyan AA (2005) The chemistry and molecular biology of new brain cytokines. Proceedings of the International Scientific Conference dedicated to the 75th anniversary of YSMU, Yerevan, pp 135-136
25. Pellizzari R, Guidi-Rontani C, Vitale G, Mick U, Montecucco C (1999) Anthrax lethal factor cleves MkK3 in macrophages and inhibits the LPS/IFN gamma-induced release of NO and TNFalpha. FEBS Lett 462:199-204
26. Park JM, Greten FR, Li ZW, Karin M (2002) Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297(5589):2048-2051
27. Guidi-Ronfani Ch, Levy M, Ohayon H, Mock M (2002) Fate of germinated Bacillus anthracis spores in primary macrophages. Mol Microbiol 42(4):931
28. Rontani Chantal-Guidi, Leve Martine, Ohayon Helene, Mock Michele (2001) Fate of germinated Bacillus anthracis spores in primary murine macrophages. Mol Microbiol 42(4):931
29. Pickering AK, Merkel TJ (2004) Macrophages release tumor necrosis factor alpha and Interleukin-12 in response to intracellular Bacillus anthracis spores. Infect Immun 72:3069-3072
30. Dixon TC, Fahd AA, Koehler TM, Swanson JA, Hanna PC (2000) Early events in anthrax pathogenesis, intracellular survival of B. anthracis and escape RAW 264.7 macrophages. Cell Microbiol 2:453-463